Showing results (11-20 of 117) with videos related to

Sort By:
Pageof 12
The Journal of Pharmacology and Experimental Therapeutics|January 16, 2004
Brain uptake of the glucagon-like peptide-1 antagonist exendin(9-39) after intranasal administrationWilliam A Banks, Matthew J During, Michael L Niehoff
Methods (San Diego, Calif.)|November 5, 2002
Promoters and regulatory elements that improve adeno-associated virus transgene expression in the brainHelen L Fitzsimons, Ross J Bland, Matthew J During
The Journal of Spinal Cord Medicine|April 10, 2002
Gene therapy for spinal cord injury and diseaseDavid J Poulsen, James S Harrop, Matthew J During
Journal of Neurochemistry|June 2, 2007
Hippocampal gene expression profiling reveals the possible involvement of Homer1 and GABA(B) receptors in scopolamine-induced amnesiaJonathan Brouillette, Deborah Young, Matthew J During, et al.
Molecular and Cellular Neurosciences|April 28, 2009
Knockdown and overexpression of NR1 modulates NMDA receptor functionMaggie L Kalev-Zylinska, Wymond Symes, Deborah Young, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 12, 2002
Recombinant adeno-associated virus serotypes 2- and 5-mediated gene transfer in the mammalian brain: quantitative analysis of heparin co-infusionMihail Y Mastakov, Kristin Baer, Robert M Kotin, et al.
Behavioral Neuroscience|February 24, 2006
Local dopamine production in the dorsal striatum restores goal-directed behavior in dopamine-deficient miceSiobhan Robinson, Bethany N Sotak, Matthew J During, et al.
Sarcoma|May 19, 2016
A Therapeutic Role for Survivin in Mitigating the Harmful Effects of Ionizing RadiationKatherine H Carruthers, Gregory Metzger, Eugene Choi, et al.
Annals of Plastic Surgery|February 14, 2013
Fat grafting as a vehicle for the delivery of recombinant adenoassociated viral vectors to achieve gene modification of muscle flapsKatherine H Carruthers, Matthew J During, Alexander Muravlev, et al.
Pageof 12